(RLAY) Relay Therapeutics - Performance -57.7% in 12m
RLAY performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-95.24%
#199 in Peer-Group
Rel. Strength
7.78%
#7087 in Stock-Universe
Total Return 12m
-57.68%
#138 in Peer-Group
Total Return 5y
-92.04%
#126 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 9.51 USD |
| 52 Week Low | 2.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 70.09 |
| Buy/Sell Signal +-5 | -0.75 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RLAY (-57.7%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: RLAY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RLAY
| Total Return (including Dividends) | RLAY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.03% | 3.06% | 3.54% |
| 3 Months | 26.81% | 12.25% | 16.07% |
| 12 Months | -57.68% | -13.98% | 12.18% |
| 5 Years | -92.04% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | RLAY | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 82.6% | 76.5% | 91.9% |
| 3 Months | 74.3% | 79.3% | 97.5% |
| 12 Months | -90.9% | -87.3% | 47% |
| 5 Years | -97.5% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th67.00 | 3.86% | 3.38% |
| 3 Month | %th66.00 | 12.97% | 9.26% |
| 12 Month | %th31.50 | -50.80% | -62.27% |
| 5 Years | %th36.50 | -89.04% | -96.17% |
FAQs
Does Relay Therapeutics (RLAY) outperform the market?
No,
over the last 12 months RLAY made -57.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months RLAY made 26.81%, while XBI made 12.25%.
Performance Comparison RLAY vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RLAY vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.8% | 3.5% | -13.7% | -70% |
| US NASDAQ 100 | QQQ | -3.3% | 2.7% | -16.2% | -71% |
| German DAX 40 | DAX | -1.9% | 5.5% | -24.5% | -86% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.4% | 2.1% | -17.7% | -77% |
| Hongkong Hang Seng | HSI | -3.4% | 4.6% | -35.7% | -92% |
| India NIFTY 50 | INDA | -1.1% | 6.5% | -15.2% | -54% |
| Brasil Bovespa | EWZ | 1.8% | 10% | -25.8% | -58% |
RLAY vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.8% | 5.2% | -17.9% | -81% |
| Consumer Discretionary | XLY | -3.2% | 4.5% | -5% | -73% |
| Consumer Staples | XLP | -0.9% | 7.8% | -14.5% | -64% |
| Energy | XLE | -0.7% | 7.3% | -3.5% | -55% |
| Financial | XLF | -1.4% | 4.5% | -13.3% | -80% |
| Health Care | XLV | -0.8% | 8.9% | -3.3% | -49% |
| Industrial | XLI | -3.2% | 2.4% | -19.6% | -79% |
| Materials | XLB | -0.2% | 5.4% | -11.6% | -58% |
| Real Estate | XLRE | -2.2% | 7.6% | -12.5% | -64% |
| Technology | XLK | -3.1% | 0.7% | -19.6% | -69% |
| Utilities | XLU | -3.6% | 5.1% | -16.4% | -79% |
| Aerospace & Defense | XAR | -5.6% | -2.2% | -34.3% | -107% |
| Biotech | XBI | -3.9% | 4% | -5.2% | -44% |
| Homebuilder | XHB | -1.1% | 1.5% | -0.4% | -51% |
| Retail | XRT | -1.6% | 4.2% | -9.6% | -63% |
RLAY vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.3% | 11.3% | 2.63% | -52% |
| Natural Gas | UNG | -7.3% | 15.5% | 10.6% | -65% |
| Gold | GLD | -3.4% | 8.7% | -31.4% | -95% |
| Silver | SLV | -5.4% | 3.3% | -30.7% | -80% |
| Copper | CPER | -4.1% | -6.6% | -32.5% | -80% |
RLAY vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.3% | 7.2% | -8.2% | -53% |
| iShares High Yield Corp. Bond | HYG | -2.3% | 6.1% | -11.8% | -66% |